272 related articles for article (PubMed ID: 32397263)
1. Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
León D; Buchegger K; Silva R; Riquelme I; Viscarra T; Mora-Lagos B; Zanella L; Schafer F; Kurachi C; Roa JC; Ili C; Brebi P
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397263
[TBL] [Abstract][Full Text] [Related]
2. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
Dogra Y; Ferguson DCJ; Dodd NJF; Smerdon GR; Curnow A; Winyard PG
Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
[TBL] [Abstract][Full Text] [Related]
3. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
Sebastian A; Allan E; Allan D; Colthurst J; Bayat A
J Dermatol Sci; 2011 Dec; 64(3):174-84. PubMed ID: 22015050
[TBL] [Abstract][Full Text] [Related]
4. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
5. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
7. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.
Anand S; Honari G; Hasan T; Elson P; Maytin EV
Clin Cancer Res; 2009 May; 15(10):3333-43. PubMed ID: 19447864
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells.
Cicarma E; Tuorkey M; Juzeniene A; Ma LW; Moan J
Br J Dermatol; 2009 Aug; 161(2):413-8. PubMed ID: 19438460
[TBL] [Abstract][Full Text] [Related]
9. Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Bay C; Togsverd-Bo K; Lerche CM; Haedersdal M
J Photochem Photobiol B; 2016 Jan; 154():34-9. PubMed ID: 26678673
[TBL] [Abstract][Full Text] [Related]
10. Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy.
Mikolajewska P; Juzeniene A; Moan J
Transl Res; 2008 Sep; 152(3):128-33. PubMed ID: 18774542
[TBL] [Abstract][Full Text] [Related]
11. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
Blake E; Allen J; Thorn C; Shore A; Curnow A
Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533
[TBL] [Abstract][Full Text] [Related]
12. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.
Lucena SR; Zamarrón A; Carrasco E; Marigil MA; Mascaraque M; Fernández-Guarino M; Gilaberte Y; González S; Juarranz A
Sci Rep; 2019 Mar; 9(1):4835. PubMed ID: 30886381
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy.
Milla LN; Cogno IS; Rodríguez ME; Sanz-Rodríguez F; Zamarrón A; Gilaberte Y; Carrasco E; Rivarola VA; Juarranz A
J Cell Biochem; 2011 Sep; 112(9):2266-78. PubMed ID: 21503960
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
17. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
18. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.
Anand S; Rollakanti KR; Horst RL; Hasan T; Maytin EV
Photochem Photobiol; 2014; 90(5):1126-35. PubMed ID: 24807677
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil Enhances Photodynamic Therapy of Squamous Cell Carcinoma via a p53-Independent Mechanism that Increases Protoporphyrin IX levels and Tumor Cell Death.
Anand S; Rollakanti KR; Brankov N; Brash DE; Hasan T; Maytin EV
Mol Cancer Ther; 2017 Jun; 16(6):1092-1101. PubMed ID: 28336806
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma.
Moon YH; Park JH; Kim SA; Lee JB; Ahn SG; Yoon JH
Head Neck; 2010 Sep; 32(9):1136-42. PubMed ID: 19953630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
